Differential level of platelet amyloid β precursor protein isoforms: An early marker for Alzheimer disease

Archives of Neurology

Volumn 55, Issue 9, 1998, Pages 1195-1200

  Di Luca, Monica ^a   Pastorino, Lucia ^a   Bianchetti, Angelo ^b   Perez, Jorge ^a   Vignolo, Luigi A ^c   Lenzi, Gian Luigi ^d   Trabucchi, Marco ^e   Cattabeni, Flaminio ^a   Padovani, Alessandro ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e GERIATRIC RESEARCH GROUP   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; THROMBOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BLOOD PLATELETS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; ISOMERISM; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; SEVERITY OF ILLNESS INDEX;

EID: 0031721665     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.9.1195     Document Type: Article

References (46)

1. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome. Biochem Biophys Res Commun. 1984;122:1131-1135.
2. Arai H, Lee VM, Otvos L Jr, et al. Defined neurofilament, τ, and β-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc Natl Acad Sci U S A. 1990;87:2249-2253.
3. Alonso AC, Zaidi T, Grundke-lqbal I, Iqbal K. Role of abnormally phosphorylated τ in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci U S A. 1994;91:5562-5566.
4. Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 1987;235:877-880.
5. Tanzi RE, Gusella JF, Watkins PC, et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage nearthe Alzheimer locus. Science. 1987;235:880-884.
6. Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease A4 protein resembles a cell surface receptor. Nature. 1987;325:733-736.
7. Ponte P, Gonzalez-DeWhitt P, Schilling J, et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 1988;331:525-527.
8. Tanzi RE, McClatchey AL, Lampert ED, Villa-Komaroff L, Gusella JF, Neve RL. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 1988;331:528-530.
9. Kitaguchi N, Takahashi Y, Takushima Y, Shiojiri S, Ito H. A novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 1988;331:530-532.
10. Selkoe DJ, Podlisny MB, Joachim CL, et al. Beta amyloid precursor protein of Alzheimer's disease occurs as 110-to 135-kDa membrane-associated proteins in neural and non-neural tissues. Proc Natl Acad Sci U S A. 1988;85:7341-7345.
11. Golde TE, Estes S, Usiak M, Younkin L, Younkin S. Expression of β-amyloid protein precursor mRNAs. Neuron. 1990;4:253-267.
12. Vanley CT, Anguilar MJ, Kleinhenz RT, Lagios MD. Cerebral amyloidangiopathy. Hum Pathol. 1981;12:609-616.
13. Joachim CL, Mori H, Selkoe D. Amyloid beta protein deposition in tissues other than brain in Alzheimer's disease. Nature. 1989;341:226-230.
14. Selkoe DJ. Molecular pathology of amyloidogenic proteins and the role of amyloidosis in Alzheimer's disease. Neurobiol Aging. 1989;10:387-395.
15. Perlmutter LS, Chang C. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res Bull. 1990;24:677-686.
16. Armstrong RA. Is the clustering of β-amyloid (Aβ) deposits in the frontal cortex of Alzheimer patients determined by blood vessels? Neurosci Lett. 1995;195:121-124.
17. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. Beta-amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 1996;380:168-171.
18. Li QX, Evin G, Small DH, Multhaup G, Beyreuther K, Masters CL. Proteolytic processing of Alzheimer's disease βA4 amyloid precursor protein in human platelets. J Biol Chem. 1995;270:14140-14147.
19. Ghilardi JR, Catton M, Stimson ER, et al. Intra-arterial infusion of [I-125]A-β-1-40 labels amyloid deposits in the aged primate brain in vivo. Neuroreport. 1996; 7:2607-2611.
20. Shayo M, McLay RN, Kastin AJ, Bands WA. The putative blood-brain barrier transporter for the β-amyloid binding protein apolipoprotein J is saturated at physiological concentrations. Life Sci. 1997;60:PL115-PL118.
21. Bush AL, Martins RN, Rumble B, et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem. 1990;265:15977-15983.
22. Schlossmacher MG, Ostaszewski BL, Hecker LI, et al. Detection of different isoforms patterns of the β-amyloid precursor protein in human platelets and lymphocytes. Neurobiol Aging. 1992;13:421-434.
23. Chen W, Inestrosa NC, Ross GS, Fernandez HL. Platelets are the primary source of amyloid β-peptide in human blood. Biochem Biophys Res Commun. 1995; 213:96-103.
24. Gardella JE, Ghiso J, Gorgone GA, et al. Intact Alzheimer amyloid precursor protein (APP) is present in platelet membrane and is encoded by platelet mRNA. Biochem Biophys Res Commun. 1990;173:1292-1298.
25. Gardella JE, Gorgone GA, Newman P, Frangione B, Gorevic PD. Characterization of Alzheimer amyloid precursor protein transcripts in platelets and megakaryocytes. Neurosci Lett. 1992;138:229-232.
26. Cole GM, Galasko D, Shapiro IP, Saitoh T. Stimulated platelets release amyloid β-protein precursor. Biochem Biophys Res Commun. 1990;170:288-295.
27. Van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD. Protease nexin II (amyloid β protein precursor): a platelet α-granule protein. Science. 1990;248:745-748.
28. Smith RP, Higuchi DA, Broze GJ Jr. Platelet coagulation factor Xla-inhibitor, a form of Alzheimer amyloid precursor protein. Science. 1990;248:1126-1128.
29. Davies TA, Fine RE, Johnson RJ, et al. Non-age related differences in thrombin responses by platelets from male patients with advanced Alzheimer's disease. Biochem Biophys Res Commun. 1993;194:537-543.
30. Davies TA, Long HJ, Sgro K, et al. Activated Alzheimer disease platelets retain more β amyloid precursor protein. Neurobiol Aging. 1997;18:147-153.
31. Davies TA, Long HJ, Tibbles HE, et al. Moderate and advanced Alzheimer's patients exhibit platelet activation differences. Neurobiol Aging. 1997;18:155-162.
32. Di Luca M, Pastorino L, Cattabeni F, et al. Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome. Arch Neurol. 1996;53:1162-1166.
33. Rosenberg RN, Bashin F, Fosmire JA, et al. Altered amyloid protein processing in platelets of patients with Alzheimer disease. Arch Neurol. 1997;54:139-144.
34. Zubenko GS, Wusylko M, Cohen BM, Boller F, Teply I. Family study of platelet membrane fluidity in Alzheimer's disease. Science. 1987;238:539-542.
35. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Neurology. 1984;34:939-944.
36. Perez J, Zanardi R, Mori S, Gasperini M, Smeraldi E, Racagni G. Abnormalities of c-AMP-dependent endogenous phosphorylation in platelets from patients with bipolar disorders. Am J Psychiatry. 1995;152:1204-1206.
37. Buxbaum JD, Gandy SE, Cicchetti P, et al. Processing of Alzheimer β-A4 amyloid precursor protein. Proc Natl Acad Sci U S A. 1990;87:6003-6006.
38. Caputi A, Barindelli S, Pastorino L, et al. Increased secretion of the amino-terminal fragment of amyloid precursor protein in brains of rats with constitutive up-regulation of protein kinase C. J Neurochem. 1997;68:2523-2529.
39. Wasco W, Gurubhagavatula S, Paradis MD, et al. Isolation and characterization of APLP 2 encoding a homologue of the Alzheimer's associated amyloid β-protein precursor. Nat Genet. 1993;5:95-100.
40. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
41. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
42. Whyte S, Wilson N, Currie J, et al. Collection and normal levels of the amyloid precursor protein in plasma. Ann Neurol. 1997;41:121-124.
43. Vigo-Pelfrey C, Seubert P, Barbour R, et al. Elevation of microtubule-associated protein τ in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology. 1995;45:788-793.
44. Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D. Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 1995;38:643-648.
45. Lannfelt L, Basun H, Wahlund LO, Rowe BA, Wagner SL. Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nature. 1995;1:829-832.
46. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci U S A. 1995;92:4725-4727.